The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISTH 2022 | Safety & efficacy of TPO-RAs in elderly patients with ITP
Priyanka Raheja
• 12 Jul 2022
Priyanka Raheja, MBBS, MD, Royal London Hospital, London, UK, briefly discusses the results of a real-world study of the UK adult immune thrombocytopenia (ITP) registry investigating the safety and efficacy of thrombopoietin receptor agonists (TPO-RAs) in older patients with primary ITP. This interview took place at the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 held in London, UK.
Disclosures
Consultant: Pfizer, Sobi, Idogen, Takeda
